Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Sanjay Sethi, Brendan Clark, Lindsay GS Bengtson, Erin K Buysman, Swetha Palli, Andrew Sargent, Asif Shaikh & Gary T Ferguson. (2023) Healthcare Resource Utilization, Cost and Clinical Outcomes in Patients Diagnosed with COPD Initiating Tiotropium Bromide/Olodaterol versus Fluticasone Furoate/Umeclidinium/Vilanterol Based on Exacerbation History. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 625-641.
Read now
Read now
Stephen A. Brunton & D. Kyle Hogarth. (2023) Overuse of long-acting β2-agonist/inhaled corticosteroids in patients with chronic obstructive pulmonary disease: time to rethink prescribing patterns. Postgraduate Medicine 0:0, pages 1-19.
Read now
Read now
Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald & Claus F Vogelmeier. (2022) Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2355-2367.
Read now
Read now
Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Read now
Arschang Valipour, Zaurbek Aisanov, Sergey Avdeev, Vladimir Koblizek, Ivan Kocan, Ivan Kopitovic, Gergely Lupkovics, Milena Man, Maris Bukovskis, Neven Tudoric, Marija Vukoja, Wojciech Naumnik & Nikolay Yanev. (2022) Recommendations for COPD management in Central and Eastern Europe. Expert Review of Respiratory Medicine 16:2, pages 221-234.
Read now
Read now
Wei-Chun Huang, Chih-Yu Chen, Wei-Chih Liao, Biing-Ru Wu, Wei-Chun Chen, Chih-Yen Tu, Chia-Hung Chen & Wen-Chien Cheng. (2021) A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1555-1568.
Read now
Read now
Leah B Sansbury, Chanchal Bains, David A Lipson, Afisi S Ismaila & Sarah H Landis. (2021) Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1255-1264.
Read now
Read now
Roland Buhl, Michael Dreher, Stephanie Korn, Christian Taube, Christian Stock, Christoph M Zehendner, Anke Kondla & Claus F Vogelmeier. (2020) A Non-Interventional Study of Tiotropium/Olodaterol versus Any Triple Combination Therapy for Chronic Obstructive Pulmonary Disease: The EVELUT® Study Protocol. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2601-2608.
Read now
Read now
Tanja Plate, Felix W Friedrich & Jutta Beier. (2020) Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1335-1347.
Read now
Read now
Faustine Dalon, Nicolas Roche, Manon Belhassen, Maëva Nolin, Hervé Pegliasco, Gaëtan Deslée, Bruno Housset, Philippe Devillier & Eric Van Ganse. (2019) Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1839-1854.
Read now
Read now
Alan Kaplan, Kenneth R Chapman, Syed M Anees, Irvin Mayers, Driss Rochdi, Michel Djandji, David Préfontaine & Andrew McIvor. (2019) Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 249-260.
Read now
Read now
Articles from other publishers (13)
Sanjay SethiSwetha R PalliLindsay G S BengtsonErin K BuysmanBrendan ClarkAndrew SargentAsif ShaikhGary T Ferguson. (2023) Clinical and economic outcomes in patients with chronic obstructive pulmonary disease initiating maintenance therapy with tiotropium bromide/olodaterol or fluticasone furoate/umeclidinium/vilanterol. Journal of Managed Care & Specialty Pharmacy 29:7, pages 791-806.
Crossref
Crossref
Michelle Vega-Olivo, David M.G. Halpin, MeiLan K. Han, Nicola A. Hanania, Ravi Kalhan, David A. Lipson, Neil MacIntyre, Dawn Midwinter, Marjorie Stiegler, Corinne Young, Fernando J. Martinez & Gerard J. Criner. (2022) Best Practice Management of Patients With Chronic Obstructive Pulmonary Disease: A Case-Based Review. The Journal for Nurse Practitioners 18:7, pages 730-735.
Crossref
Crossref
Wei Cheng, Jiaxi Duan, Aiyuan Zhou, Yiyang Zhao, Rong Yi, Yi Liu, Dingding Deng, Xin Li, Yuqin Zeng, Yating Peng, Qing Song, Ling Lin, Min Yang & Ping Chen. (2021) Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Antonio Anzueto & Alan Kaplan. (2020) Dual bronchodilators in chronic obstructive pulmonary disease: Evidence from randomized controlled trials and real-world studies. Respiratory Medicine: X 2, pages 100016.
Crossref
Crossref
Swetha R. PalliMonica FrazerMary DuCharmeAmi R. BuikemaAmy J. AndersonJessica Franchino-Elder. (2020) Differences in Real-World Health and Economic Outcomes Among Patients with COPD Treated with Combination Tiotropium/Olodaterol Versus Triple Therapy. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1363-1374.
Crossref
Crossref
Jørgen Vestbo, Christer Janson, Javier Nuevo & David Price. (2020) Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. ERJ Open Research 6:4, pages 00044-2020.
Crossref
Crossref
Eleanor L Axson, Adam Lewis, James Potts, Marie Pang, Scott Dickinson, Helene Vioix & Jennifer K Quint. (2020) Inhaled therapies for chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open 10:9, pages e036455.
Crossref
Crossref
Peter Kardos, Claus F. Vogelmeier, Heinrich Worth, Roland Buhl, Victoria Obermoser & Carl-Peter Criée. (2020) COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study. Lung 198:3, pages 507-514.
Crossref
Crossref
Daiana Stolz & Marc Miravitlles. (2020) The right treatment for the right patient with COPD: lessons from the IMPACT trial. European Respiratory Journal 55:5, pages 2000881.
Crossref
Crossref
Swetha R Palli, Ami R Buikema, Mary DuCharme, Monica Frazer, Shuchita Kaila & Timothy Juday. (2019) Costs, exacerbations and pneumonia after initiating combination tiotropium olodaterol versus triple therapy for chronic obstructive pulmonary disease. Journal of Comparative Effectiveness Research 8:15, pages 1299-1316.
Crossref
Crossref
Jaco Voorham, Massimo Corradi, Alberto Papi, Claus F. Vogelmeier, Dave Singh, Leonardo M. Fabbri, Marjan Kerkhof, Janwillem H. Kocks, Victoria Carter & David Price. (2019)
Comparative effectiveness of triple therapy
versus
dual bronchodilation in COPD
. ERJ Open Research 5:3, pages 00106-2019.
Crossref
Crossref
Juan Carlos Vázquez-García, Rafael de Jesús Hernández-Zenteno, José Rogelio Pérez-Padilla, María del Carmen Cano-Salas, Margarita Fernández-Vega, Jorge Salas-Hernández, Marco Antonio Figueroa-Morales, Rosaura Esperanza Benítez-Pérez, Luis Adrián Rendón-Pérez, Jesús Vázquez-Cortés, Mayra Edith Mejía-Ávila, José Luis Mayorga-Butrón, Moisés Acuña-Kaldman, Rocío Barriga-Acevedo, Alma Rosa Bizarrón-Muro, Robert Camargo-Ángeles, Catalina Casillas-Suárez, Celia Oralia Castañeda-Hernández, Rafael Patricio Castañón-Rodríguez, Juan Francisco Castillo-Sánchez, Arturo Cortés-Télles, Jesús Javier Díaz-Castañón, Abelardo Elizondo Ríos, María Guadalupe Espitia-Hernández, Martha Angélica García-Avilés, Rogelio García-Torrentera, Julio Edgardo González Aguirre, Fernando Carlos Guillén-Ortega, José Carlos Herrera-García, Marco Antonio Loustaunau-Andrade, Gerardo Ezequiel Magdaleno Maldonado, Luz Audina Mendoza Topete, José Padua-García, Andrés Palomar-Lever, Rafael Francisco Páramo-Arroyo, Saraí del Carmen Toral-Freyre, José Felipe Villegas-Elizondo & Edgar Gerardo Zozoaga-Velázquez. (2019) Guía de Práctica Clínica Mexicana para el diagnóstico y tratamiento de la Enfermedad Pulmonar Obstructiva Crónica <br>GUÍA MEXICANA DE EPOC, 2020. NCT Neumología y Cirugía de Tórax 78:S1, pages 4-76.
Crossref
Crossref
I. V. Leshchenko. (2018) Possibilities and limitations of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease. Russian Pulmonology 28:5, pages 602-612.
Crossref
Crossref